DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Thomas MB, Morris JS, Chadha R , et al.
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.

J Clin Oncol 2009;
27 (6) 843-850

Download Bibliographical Data

Search in:
Access: